Continuous Home Monitoring

Care for ambulatory and post-cardiac patients often necessitates continuous monitoring of vital signs. Arrhythmia and myocardial ischemia, in particular, can occur sporadically and easily forego detection by a standard EKG reading. The SmartShirt can continuously collect and transmit vital signs data to existing monitors or the Internet. The first commercial generation of the Smart Shirt System will monitor EKG, heart rate, respiration, temperature, and pulse oximetry readings. The SmartShirt can also be used to monitor vital signs data in infants with disorders such as apnea, airway obstruction, prematurity, respiratory synctial virus, gastroesophageal reflux, and seizure disorders.


Remote Patient Examination

The SmartShirt System can also provide remote examination capability for patients in nursing homes, at home, or even while being transported via ambulance. The System will be able to collect health data in a comfortable manner and will also ensure that sensors are properly placed on the patient. The data can then be transmitted to the patientís physician or a facility (including the emergency room) that possesses the proper expertise to assess the patientís condition. The system for this application will include the capabilities described previously and will also provide capability for 12-lead EKG (with new sensors that are embedded into the garment), remote stethoscope monitoring, and voice communication with the patient.


Infant Vital Signs Monitoring

Infants can be prescribed home vital signs monitoring for a host of different indications, some of which include apnea, prematurity, gastroesophageal reflux, infantile spasms. New trends in pediatrics are also contributing to an increase in the use of home monitoring. Infants under one year of age with Influenza or Respiratory Synctial Virus (RSV) are being less frequently detained at the hospital, and more often treated at home with the assistance of a vital signs monitor. With 33% of newborns likely to suffer from Influenza before the age of one, and more than twice that number for RSV, the growing trend in medical practice towards home monitoring could make the infant monitoring market potentially very large. Image shows Infant being monitored by 3rd Generation Prototype of Sensatex Smart Shirt


Sleep Studies Monitoring

There are estimated to be 40 million people in the United States with chronic sleep disorders. These include 18 million adults with sleep apnea, as well as those with insomnia and narcolepsy. Loud snoring, observed episodes of apnea, nocturnal choking, daytime sleepiness, hypertension, and moderate to severe obesity are all symptoms of sleep-related disorders. Of this vast population, 95% go untreated, due probably to the inconvenience of full-channel polysomnography (PSG), the traditional method of diagnosis. The Sensatex sleep study product, with a sensor suite to measure EKG, pulse oximetry, and body position, if proven convenient and effective, has the potential to awaken a vastly untapped market.


For more info, please email Sensatex.